CoChat
Cited by 55

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

De Novo Mutations Activating Germline TP53 in an Inherited Bone-Marrow-Failure Syndrome

Toki, Tsutomu, Yoshida, Kenichi, Wang, RuNan, Nakamura, Sou, Maekawa, Takanobu, Goi, Kumiko, Katoh, Megumi C., Mizuno, Seiya, Sugiyama, Fumihiro, Kanezaki, Rika, Uechi, Tamayo, Nakajima, Yukari, Sato, Yusuke, Okuno, Yusuke, Sato-Otsubo, Aiko, Shiozawa, Yusuke, Kataoka, Keisuke, Shiraishi, Yuichi, Sanada, Masashi, Chiba, Kenichi, Tanaka, Hiroko, Terui, Kiminori, Sato, Tomohiko, Kamio, Takuya, Sakaguchi, Hirotoshi, Ohga, Shouichi, Kuramitsu, Madoka, Hamaguchi, Isao, Ohara, Akira, Kanno, Hitoshi, Miyano, Satoru, Kojima, Seiji, Ishiguro, Akira, Sugita, Kanji, Kenmochi, Naoya, Takahashi, Satoru, Eto, Koji, Ogawa, Seishi, Ito, Etsuro · 2018 · The American Journal of Human Genetics

Abstract

Inherited bone-marrow-failure syndromes (IBMFSs) include heterogeneous genetic disorders characterized by bone-marrow failure, congenital anomalies, and an increased risk of malignancy. Many lines of evidence have suggested that p53 activation might be central to the pathogenesis of IBMFSs, including Diamond-Blackfan anemia (DBA) and dyskeratosis congenita (DC). However, the exact role of p53 activation in each clinical feature remains unknown. Here, we report unique de novo TP53 germline variants found in two individuals with an IBMFS accompanied by hypogammaglobulinemia, growth retardation, and microcephaly mimicking DBA and DC. TP53 is a tumor-suppressor gene most frequently mutated in human cancers, and occasional germline variants occur in Li-Fraumeni cancer-predisposition syndrome. Most of these mutations affect the core DNA-binding domain, leading to compromised transcriptional activities. In contrast, the variants found in the two individuals studied here caused the same truncation of the protein, resulting in the loss of 32 residues from the C-terminal domain (CTD). Unexpectedly, the p53 mutant had augmented transcriptional activities, an observation not previously described in humans. When we expressed this mutant in zebrafish and human-induced pluripotent stem cells, we observed impaired erythrocyte production. These findings together with close similarities to published knock-in mouse models of TP53 lacking the CTD demonstrate that the CTD-truncation mutations of TP53 cause IBMFS, providing important insights into the previously postulated connection between p53 and IBMFSs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ajhg.2018.07.020

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 19

  1. Bessler, M., Masson, P.J., Link, D.C., and Wilson, D.B. Inherited bone marrow failure syndrome. In Nathan and Oski’s Hematology of Infancy and Childhood, 7th edition. S.H. Orkin, D.G. Nathan, D. Ginsburg, A.T. Look, D.E. Fisher, and S.E. Lux, eds. (W.B. Saunders), pp. 307–395.
  2. Dutt, 2011, Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells, Blood, 117, 2567, 10.1182/blood-2010-07-295238 · DOI · Paper page
  3. Townsley, 2014, Bone marrow failure and the telomeropathies, Blood, 124, 2775, 10.1182/blood-2014-05-526285 · DOI · Paper page
  4. Vlachos, 2008, Diagnosing and treating Diamond Blackfan anaemia: Results of an international clinical consensus conference, Br. J. Haematol., 142, 859, 10.1111/j.1365-2141.2008.07269.x · DOI · Paper page
  5. Narla, 2010, Ribosomopathies: Human disorders of ribosome dysfunction, Blood, 115, 3196, 10.1182/blood-2009-10-178129 · DOI · Paper page
  6. Calado, 2009, Telomere diseases, N. Engl. J. Med., 361, 2353, 10.1056/NEJMra0903373 · DOI · Paper page
  7. Jyonouchi, 2011, Dyskeratosis congenita: A combined immunodeficiency with broad clinical spectrum--a single-center pediatric experience, Pediatr. Allergy Immunol., 22, 313, 10.1111/j.1399-3038.2010.01136.x · DOI
  8. Vulliamy, 2006, Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation, Blood, 107, 2680, 10.1182/blood-2005-07-2622 · DOI · Paper page
  9. Khan, 2011, Do ribosomopathies explain some cases of common variable immunodeficiency?, Clin. Exp. Immunol., 163, 96, 10.1111/j.1365-2249.2010.04280.x · DOI
  10. Alter, 2007, Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita, Blood, 110, 1439, 10.1182/blood-2007-02-075598 · DOI · Paper page
  11. Kunishima, 2013, ACTN1 mutations cause congenital macrothrombocytopenia, Am. J. Hum. Genet., 92, 431, 10.1016/j.ajhg.2013.01.015 · DOI · Paper page
  12. Kandoth, 2013, Mutational landscape and significance across 12 major cancer types, Nature, 502, 333, 10.1038/nature12634 · DOI · Paper page
  13. Malkin, 2016, CANCER. The cancer predisposition revolution, Science, 352, 1052, 10.1126/science.aag0832 · DOI
  14. Ochi, 2014, Multicolor staining of globin subtypes reveals impaired globin switching during erythropoiesis in human pluripotent stem cells, Stem Cells Transl. Med., 3, 792, 10.5966/sctm.2013-0216 · DOI
  15. Laptenko, 2016, The tail that wags the dog: How the disordered C-terminal domain controls the transcriptional activities of the p53 tumor-suppressor protein, Trends Biochem. Sci., 41, 1022, 10.1016/j.tibs.2016.08.011 · DOI · Paper page
  16. Huang, 2006, Repression of p53 activity by Smyd2-mediated methylation, Nature, 444, 629, 10.1038/nature05287 · DOI · Paper page
  17. Wang, 2016, Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode, Nature, 538, 118, 10.1038/nature19759 · DOI · Paper page
  18. Simeonova, 2013, Mutant mice lacking the p53 C-terminal domain model telomere syndromes, Cell Rep., 3, 2046, 10.1016/j.celrep.2013.05.028 · DOI
  19. Hamard, 2013, The C terminus of p53 regulates gene expression by multiple mechanisms in a target- and tissue-specific manner in vivo, Genes Dev., 27, 1868, 10.1101/gad.224386.113 · DOI

Cited by

See all 55

Metadata

Authors
Toki, T., Yoshida, K., Wang, R., Nakamura, S., Maekawa, T., Goi, K., Katoh, M. C., Mizuno, S., Sugiyama, F., Kanezaki, R., Uechi, T., Nakajima, Y., Sato, Y., Okuno, Y., Sato-Otsubo, A., Shiozawa, Y., Kataoka, K., Shiraishi, Y., Sanada, M., Chiba, K., Tanaka, H., Terui, K., Sato, T., Kamio, T., Sakaguchi, H., Ohga, S., Kuramitsu, M., Hamaguchi, I., Ohara, A., Kanno, H., Miyano, S., Kojima, S., Ishiguro, A., Sugita, K., Kenmochi, N., Takahashi, S., Eto, K., Ogawa, S., & Ito, E.
Venue
The American Journal of Human Genetics
Publisher
Elsevier BV
Published
2018-09
Volume
103
Issue
3
Pages
440-447
ISSN
0002-9297
Cited by
55
References
4
Language
en
Licence
Funders
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science (JP 17K10093)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.